The Inherited Metabolic Disorders Testing market was valued at USD 603.40 Million in 2022 and is expected to reach USD 1,125.15 Million by 2030, growing at a CAGR of 8.1% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.